Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2020

01-12-2020 | Cytostatic Therapy | Pancreatic Tumors

Comments on “Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma”

Authors: Vincenza Granata, MD, Roberta Fusco, PhD, Raffaele Palaia, MD, Andrea Belli, MD, Antonella Petrillo, MD, Francesco Izzo, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

To the editor …
Literature
1.
Bhutiani N, Li Y, Zheng Q, Pandit H, Shi X, Chen Y, et al. Electrochemotherapy with irreversible electroporation and FOLFIRINOX improves survival in murine models of pancreatic adenocarcinoma. Ann Surg Oncol. 2020;27(11):4348–59.
2.
He J. Electrochemotherapy for pancreatic cancer: an emerging treatment modality? Ann Surg Oncol. 2020;27:4086–7.
3.
Martin RC, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg. 2015;262:486–94; discussion 492–4.
4.
He C, Wang J, Zhang Y, Lin X, Li S. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: a propensity score-matching analysis. Pancreatology. 2020;20:477–84.CrossRef
5.
Mir LM, Orlowski S. Mechanisms of electrochemotherapy. Adv Drug Deliv Rev. 1999;35:107–18.CrossRef
6.
Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand. 2003;177:437–47.CrossRef
7.
Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, Izzo F. Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg. 2015;18:230–6.CrossRef
8.
Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, et al. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World J Gastroenterol. 2017;23:4767–78.CrossRef
9.
Izzo F, Ionna F, Granata V, Albino V, Patrone R, Longo F, et al. New deployable expandable electrodes in the electroporation treatment in a pig model: a feasibility and usability preliminary study. Cancers Basel. 2020;12:515.CrossRef
10.
11.
Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, Claudio B. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol. 2015;49:147–54.CrossRef
12.
Granata V, Palaia R, Albino V, Piccirillo M, Venanzio Setola S, Petrillo A, Izzo F. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report. Eur Rev Med Pharmacol Sci. 2020;24:7051–7.PubMed
13.
Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, et al. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study. World J Gastroenterol. 2017;23:906–18.CrossRef
Metadata
Title
Comments on “Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma”
Authors
Vincenza Granata, MD
Roberta Fusco, PhD
Raffaele Palaia, MD
Andrea Belli, MD
Antonella Petrillo, MD
Francesco Izzo, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09183-1

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue

ASO Author Reflections

ASO Author Reflection: Getting Closer to Solving the Mystery Behind Mastalgia: Evening Primrose Oil and Factors Affecting Its Therapeutic Efficacy

ASO Author Reflections

ASO Author Reflections: Relationship of Cancer Diagnosis to Complications Following Pancreatoduodenectomy for Duodenal Adenoma: Extreme Force Versus the Right Weapon for the Right Problem

ASO Author Reflections

ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer

ASO Author Reflections

ASO Author Reflections: A Novel Classification System to Predict Outcome in Solid Pseudopapillary Tumor of the Pancreas

ASO Author Reflections

ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

Correction

Correction to: Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management